Philip Janiak

2.3k total citations
53 papers, 1.7k citations indexed

About

Philip Janiak is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Philip Janiak has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Cardiology and Cardiovascular Medicine and 13 papers in Surgery. Recurrent topics in Philip Janiak's work include Nitric Oxide and Endothelin Effects (6 papers), Cardiac Ischemia and Reperfusion (6 papers) and Hormonal Regulation and Hypertension (5 papers). Philip Janiak is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Cardiac Ischemia and Reperfusion (6 papers) and Hormonal Regulation and Hypertension (5 papers). Philip Janiak collaborates with scholars based in France, United States and Germany. Philip Janiak's co-authors include J.-P. Vilaine, Jean‐Pierre Bidouard, Arnaud Pillon, Stephen E. O'Connor, Jean‐François Prost, Bruno Poirier, Michael J. Brody, J. M. Herbert, Jean Marc Herbert and Gérard Le Fur and has published in prestigious journals such as Circulation, PLoS ONE and Circulation Research.

In The Last Decade

Philip Janiak

51 papers receiving 1.7k citations

Peers

Countries citing papers authored by Philip Janiak

Since Specialization

Citations

This map shows the geographic impact of Philip Janiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Janiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Janiak more than expected).

Fields of papers citing papers by Philip Janiak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Janiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Janiak. The network helps show where Philip Janiak may publish in the future.

Co-authorship network of co-authors of Philip Janiak

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Janiak. A scholar is included among the top collaborators of Philip Janiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Janiak. Philip Janiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Score assessment and treatment in patients presenting with low anterior resection syndrome after sphincter-sparing rectal cancer surgery 2025 ·International Journal of Colorectal Disease ·(unknown), (unknown), (unknown), (unknown), Bertie Geng, Philip Janiak, L. Bühler, Bernhard Egger	0
2	Observational Study for Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure (EVOLUTION) 2024 ·European Journal of Heart Failure ·Gad Cotter, Beth A. Davison, Philip Janiak, Christopher Edwards, Maria Novosadova, Koji Takagi, Marie‐Laure Ozoux, Francesca Lawson, Hamlet Hayrapetyan, Hamayak Sisakian, (unknown), Katell Peoc’h, (unknown), (unknown), (unknown), Alexandre Mebazaa	2
3	R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases 2024 ·British Journal of Pharmacology ·Bruno Poirier, Olivier Pasquier, (unknown), Alain Corbier, Philippe Prigent, (unknown), Carine Bernard, (unknown), (unknown), (unknown), (unknown), Raffaele Ingenito, (unknown), Olivier Duclos, (unknown), Bernard Maillère, Elisabetta Bianchi, Sergio Mallart, Philip Janiak, Stéphane Illiano	6
4	Long-acting CRF2 peptide agonist improves cardiac function in a rat heart failure model 2023 ·European Heart Journal ·(unknown), (unknown), Philip Janiak, Paul Mulder	1
5	High Glucose Activates YAP Signaling to Promote Vascular Inflammation 2021 ·Frontiers in Physiology ·(unknown), Jean-Christophe Le Bail, Elise F. Villard, Bertrand Léger, Bruno Poirier, (unknown), Sandra Beeské, (unknown), Véronique Blanchard, (unknown), Souâd Naimi, Philip Janiak, Etienne Guillot, Marco Meloni	19
6	Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse 2020 ·British Journal of Pharmacology ·(unknown), Bertrand Léger, Clara Dees, Christian Beyer, Alfiya Distler, Serena Vettori, (unknown), Jean‐Pierre Bidouard, Matthias Schaefer, Josef Pernerstorfer, Hartmut Ruetten, Alexandre Jagerschmidt, Philip Janiak, Jörg H. W. Distler, Oliver Distler, Stéphane Illiano	20
7	Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities 2020 ·Journal of Pharmacology and Experimental Therapeutics ·Marie‐Laure Ozoux, (unknown), Michel Pelat, (unknown), Paul Schaeffer, Philippe Beauverger, Bruno Poirier, Jean‐Michel Guillon, Frédéric Petit, J.M. Altenburger, Jean‐Pierre Bidouard, Philip Janiak	7
8	Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures 2020 ·Journal of Pharmacology and Experimental Therapeutics ·Etienne Guillot, Jean-Christophe Le Bail, Pascal Paul, (unknown), Pascale Briand, Michel Partiseti, Charles Cornet, Philip Janiak, (unknown)	6
9	Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ 2019 ·Scientific Reports ·Cecilia Hurtado, (unknown), Michael P. Smith, (unknown), Arne A.N. Bruyneel, Jorge Gomez‐Galeno, Franz Oswald, Christopher J. Larson, John R. Cashman, Pilar Ruiz‐Lozano, Philip Janiak, (unknown), Mark Mercola	40
10	PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate 2018 ·Clinical Science ·Mikaël Croyal, (unknown), (unknown), Jean-Christophe Le Bail, Elise F. Villard, Bruno Poirier, Audrey Aguesse, Stéphanie Billon‐Crossouard, Stéphane Ramin‐Mangata, Valentin Blanchard, Brice Nativel, Kévin Chemello, (unknown), Aurélie Thedrez, Philip Janiak, Michel Krempf, Christophe Boixel, Gilles Lambert, Etienne Guillot	35
11	Abstract 20593: In vivo Cardiac Effects of Mavacamten (MYK-461): Evidence for Negative Inotropy and Improved Compliance 2017 ·Circulation ·Carlos del Río, Yukie Ueyama, Dale C. Baker, (unknown), (unknown), Philip Janiak, (unknown), Joseph L. Lambing, Marc Evanchik, Eric M. Green	5
12	PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo 2016 ·JACC Basic to Translational Science ·Elise F. Villard, Aurélie Thedrez, Jörg Blankenstein, Mikaël Croyal, (unknown), Bruno Poirier, Jean-Christophe Le Bail, Stéphane Illiano, Estelle Nobécourt, Michel Krempf, Dirk Blom, A. David Marais, Philip Janiak, Anthony J. Muslin, Etienne Guillot, Gilles Lambert	93
13	Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats 2007 ·Kidney International ·Philip Janiak, Bruno Poirier, Jean‐Pierre Bidouard, (unknown), (unknown), (unknown), Isabelle Barbosa, Jürgen Dedio, J.P. Maffrand, G. Le Fur, Stephen O’Connor, Jean Marc Herbert	107
14	Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats 2006 ·European Journal of Pharmacology ·Philip Janiak, Jean‐Pierre Bidouard, (unknown), Bruno Poirier, (unknown), (unknown), (unknown), Patrick Bruneval, Stephen E. O'Connor, Jean‐Marc Herbert	28
15	SSR69071, an elastase inhibitor, reduces myocardial infarct size following ischemia–reperfusion injury 2003 ·European Journal of Pharmacology ·Jean‐Pierre Bidouard, (unknown), (unknown), Jean‐Marc Herbert, Stephen E. O'Connor, Philip Janiak	17
16	SL65.0472 blocks 5-hydroxytryptamine-induced vasoconstriction in a dog hindlimb ischemia model 2003 ·European Journal of Pharmacology ·(unknown), (unknown), Jean‐Pierre Bidouard, (unknown), Stephen E. O'Connor, Philip Janiak	7
17	Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchanger 2000 ·British Journal of Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), Philip Janiak, (unknown), (unknown), (unknown), Stephen E. O'Connor	21
18	The pharmacological basis and pathophysiological significance of the heart rate‐lowering property of diltiazem 1999 ·Fundamental and Clinical Pharmacology ·Stephen E. O'Connor, (unknown), Philip Janiak	40
19	Morphological heterogeneity with normal expression but altered function of G proteins in porcine cultured regenerated coronary endothelial cells 1997 ·British Journal of Pharmacology ·Catherine Borg‐Capra, (unknown), Philip Janiak, Nicole Villeneuve, Jean‐Pierre Bidouard, Jean‐Paul Vilaine, Paul M. Vanhoutte	32
20	Endothelial effects of hemostatic devices for continuous cardioplegia or minimally invasive operations 1996 ·The Annals of Thoracic Surgery ·Louis P. Perrault, (unknown), Michel Wassef, Jean‐Pierre Bidouard, Philip Janiak, Nicole Villeneuve, (unknown), Gérard Bloch, Jean‐Paul Vilaine, Paul M. Vanhoutte	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact